DocGo’s (DCGO) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of DocGo (NASDAQ:DCGO) in a research note released on Tuesday,Benzinga reports. They currently have a $3.00 price target on the stock.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, DocGo presently has an average rating of “Hold” and an average price target of $2.50.

DocGo Stock Performance

DCGO opened at $0.66 on Tuesday. DocGo has a one year low of $0.60 and a one year high of $2.86. The company has a market cap of $64.92 million, a P/E ratio of -0.36 and a beta of 0.95. The business’s 50-day simple moving average is $0.76 and its 200-day simple moving average is $1.02.

Institutional Trading of DocGo

Several institutional investors and hedge funds have recently bought and sold shares of the business. P.A.W. Capital Corp grew its position in DocGo by 60.0% during the 2nd quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company’s stock worth $5,024,000 after purchasing an additional 1,200,000 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of DocGo by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock worth $1,984,000 after buying an additional 73,900 shares during the last quarter. Jefferies Financial Group Inc. increased its position in DocGo by 5.7% in the 2nd quarter. Jefferies Financial Group Inc. now owns 2,144,456 shares of the company’s stock valued at $3,367,000 after acquiring an additional 115,000 shares during the period. State Street Corp increased its position in DocGo by 2.0% in the 4th quarter. State Street Corp now owns 1,969,603 shares of the company’s stock valued at $1,729,000 after acquiring an additional 39,125 shares during the period. Finally, Isthmus Partners LLC raised its stake in DocGo by 13.8% during the 4th quarter. Isthmus Partners LLC now owns 888,845 shares of the company’s stock valued at $780,000 after acquiring an additional 107,592 shares during the last quarter. Hedge funds and other institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.